Saturday, December 06, 2025 | 05:25 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Over half of large-cap schemes lag Nifty100 amidst weak market breadth

17 of 37 schemes beat index's returns of -6.4%, but only 3 were positive

markets, stock market, shares, valuations, economy, gdp, growth, investment, FDI, FPI, index
premium

The Nifty50 has rallied thanks to the outperformance of a select few names such as Dr Reddy’s Laboratories, Divi’s Laboratories, Cipla, Infosys, Reliance Industries, and Wipro

Ashley Coutinho Mumbai
A little over half of the 37 large-cap schemes have underperformed the Nifty100 index year-to-date.

Seventeen schemes beat the benchmark’s returns of -6.4 per cent given this year, of which only three schemes have provided positive returns, data from Value Research shows. JM Core 11 Fund has been the worst performer, with returns of -17.6 per cent. Only regular plans were considered. 

The Nifty50 has rallied thanks to the outperformance of a select few names such as Dr Reddy’s Laboratories, Divi’s Laboratories, Cipla, Infosys, Reliance Industries, and Wipro. In the Nifty100 universe, only 29 per cent of stocks have provided double-digit returns,